Article Listing - Roche ratchets up the pressure on Illumina; analytical view

FUJISAWA LAUNCHES NOVACT M

25 May 1992

- Fujisawa Pharmaceutical has announced the launch of Novact M (coagulation factor IX). Originally developed by the Chemo-Sero-Therapeutic Research...

NASAL ASPIRIN

25 May 1992

- Researchers at the University of Kentucky have developed an asprin solution to be administered via a nasal spray. The...

APPOINTMENTS AT OTSUKA

25 May 1992

- Appointments at Otsuka: Tamotsu Fujino becomes vice director, liaison with licensors, at the Tokyo office of corporate planning; Jun'ichi...

PFIZER'S DIFLUCAN LAUNCHED IN NIGERIA

25 May 1992

- Pfizer Products has launched its new anti-fungal agent Diflucan (fluconazole) in Nigeria. Its clinical efficacy and saftey has been...

IMMUNE RESPONSE AND R-PR: AIDS INVESTMENT

25 May 1992

- Immune Response Corp and Rhone-Poulenc Rorer have agreed a further investment of $9 million each in their joint AIDS...

US SELF-MEDICATION STUDIED

25 May 1992

When Americans have colds, headaches and other common ailments, they now use over-the-counter medicines 38% of the time, compared with...

UK BIOTECH COS PLAN FLOTATIONS

25 May 1992

Two of the UK's largest biotechnol-ogy concerns, Celltech and British Biotechnology, have plans to float their companies on the stock...

US BIOTECH COS NEED GOVT SUPPORT

25 May 1992

Unless concrete steps are taken by the government, industries and universities to ensure that there is a two-way exchange of...

SYNTHELABO INTENDS TO UP INTERNATIONAL STATUS

25 May 1992

At Synthelabo's first meeting with analysts, the company reviewed 1991 results, set out the rationale behind recent acquisitions and discussed...

BAYER ESPANA'S 1991 PROFITS DOWN 21.4%

25 May 1992

Bayer Espana, Spanish subsidiary of the German pharmaceutical group, Bayer, made consolidated pretax profits of 8.9 billion pesetas ($86 million)...

Showing 94031-94040 of 95572 articles